FreedomEdgeTM F10020Recalls & reported problems
Repro Med Systems, Inc. · Mechanical Syringe Infusion Pump · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00659443000018), received between Mar 31, 2020 and Mar 31, 2020 — classified as 1 malfunction.
The most frequently reported specific device problem is “Infusion or Flow Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Infusion or Flow Problem1
Patient problems
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 31, 2020Infusion or Flow Problem
THE CUSTOMER REPORTED A PATIENT WAS ABLE TO START AN INFUSION OMMITTING THE USE OF FLOW RATE TUBING AND DIRECTLY CONNECTING THE NEEDLE SET TO THE SYRINGE WHILE UTILIZING THE FREEDOMEDGE SYRINGE DRIVER.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9905477 ↗
Other Immunoglobulin G (IgG) Infusion System devices
- FREEDOM60® F10050Repro Med Systems, Inc. · Immunoglobulin G (IgG) Infusion System58 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page